tiprankstipranks
Trending News
More News >
Modus Therapeutics Holding AB (SE:MODTX)
:MODTX
Advertisement

Modus Therapeutics Holding AB (MODTX) Price & Analysis

Compare
0 Followers

MODTX Stock Chart & Stats


Financials

MODTX FAQ

What was Modus Therapeutics Holding AB’s price range in the past 12 months?
Modus Therapeutics Holding AB lowest stock price was kr1.12 and its highest was kr3.60 in the past 12 months.
    What is Modus Therapeutics Holding AB’s market cap?
    Modus Therapeutics Holding AB’s market cap is kr46.90M.
      When is Modus Therapeutics Holding AB’s upcoming earnings report date?
      Modus Therapeutics Holding AB’s upcoming earnings report date is Aug 27, 2025 which is in 32 days.
        How were Modus Therapeutics Holding AB’s earnings last quarter?
        Currently, no data Available
        Is Modus Therapeutics Holding AB overvalued?
        According to Wall Street analysts Modus Therapeutics Holding AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Modus Therapeutics Holding AB pay dividends?
          Modus Therapeutics Holding AB does not currently pay dividends.
          What is Modus Therapeutics Holding AB’s EPS estimate?
          Modus Therapeutics Holding AB’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Modus Therapeutics Holding AB have?
          Modus Therapeutics Holding AB has 35,938,900 shares outstanding.
            What happened to Modus Therapeutics Holding AB’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Modus Therapeutics Holding AB?
            Currently, no hedge funds are holding shares in SE:MODTX

            Company Description

            Modus Therapeutics Holding AB

            Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
            Similar Stocks
            Company
            Price & Change
            Follow
            CombiGene AB
            ExpreS2ion Biotech Holding AB
            Spago Nanomedical AB
            Sprint Bioscience AB
            Stayble Therapeutics AB
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis